Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling, D
Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients. [electronic resource] - Pathology, research and practice 2005 - 801-5 p. digital
Publication Type: Journal Article
0344-0338
10.1016/j.prp.2004.11.001 doi
Adult
Barrett Esophagus--metabolism
Biomarkers, Tumor--metabolism
Cardia--metabolism
Diagnosis, Differential
Female
Humans
Intermediate Filament Proteins--metabolism
Keratin-20
Keratin-7
Keratins--metabolism
Male
Metaplasia
Middle Aged
Predictive Value of Tests
Prospective Studies
Pyloric Antrum--metabolism
Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients. [electronic resource] - Pathology, research and practice 2005 - 801-5 p. digital
Publication Type: Journal Article
0344-0338
10.1016/j.prp.2004.11.001 doi
Adult
Barrett Esophagus--metabolism
Biomarkers, Tumor--metabolism
Cardia--metabolism
Diagnosis, Differential
Female
Humans
Intermediate Filament Proteins--metabolism
Keratin-20
Keratin-7
Keratins--metabolism
Male
Metaplasia
Middle Aged
Predictive Value of Tests
Prospective Studies
Pyloric Antrum--metabolism